Signal-transduction inhibitors in renal cell carcinoma

Authors

  • Nicholas J. Vogelzang,

    1. Nevada Cancer Institute, University of Nevada School of Medicine, Las Vegas, NV, USA, and Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy
    Search for more papers by this author
  • Cora N. Sternberg

    Corresponding author
    1. Nevada Cancer Institute, University of Nevada School of Medicine, Las Vegas, NV, USA, and Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy
    Search for more papers by this author

Cora N. Sternberg, Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
e-mail: cstern@mclink.it

Ancillary